Palmer_75-79.indd INTRODUCTION Arnold Theiler’s identification of Anaplasma margin- ale as the microbial agent of a specific disease, which he designated anaplasmosis, was only one of his remarkable achievements carried out in South Africa from the late 19th century through the early decades of the 20th. Equally as impressive was his subsequent recognition of a less virulent strain, which he termed A. marginale variety centrale, and its implementation as a vaccine—which continues in use today. [Theiler’s original taxonomy of this less virulent strain has not been subsequently amended and, according to modern nomenclature, is referred to as A. marginale subspecies centrale.] On this oc- casion of the 100th anniversary of both Theiler’s original identification of A. marginale and the found- ing of the Onderstepoort Veterinary Institute, I am honoured to have been invited to present this lec- ture and daunted by the challenge of reviewing Thei ler’s work from a centennial perspective. To man age this challenge, I will focus on only a few of the prescient observations of Theiler’s 1908–1909 report, “Anaplasma marginale (gen. and spec. nov.): The marginal points in the blood of cattle suffering from a specific disease”. DISCUSSION In this landmark paper, Theiler (1910) identified A. marginale as the etiologic agent of a specific dis- ease characterized by fever and anemia resulting in lethargy, anorexia, and a significant case fatality rate. This connection was especially notable in that the punctuate basophilic intraerythrocytic inclusions that characterize A. marginale in stained blood smears had been reported by Smith & Kilborne (1893) some 15 years earlier as stages of the proto- zoan Piroplasma bigeminum (now Babesia bigem- ina)—a reasonable conclusion given the presence of multiple distinct stages of protozoan parasites. Theiler’s initial suspicion that there were two differ- ent etiologic agents involved in what was termed 75 Onderstepoort Journal of Veterinary Research, 76:75–79 (2009) Sir Arnold Theiler and the discovery of anaplasmosis: A centennial perspective G.H. PALMER Department of Veterinary Microbiology and Pathology and School for Global Animal Health Washington State University, Pullman, Washington, USA 99164-7040 ABSTRACT PALMER, G.H. 2009. Sir Arnold Theiler and the discovery of anaplasmosis: A centennial perspective. Onderstepoort Journal of Veterinary Research, 76:75–79 Sir Arnold Theiler’s research in 1908/09 led to the discovery of the first rickettsial pathogen, Anaplasma marginale, and set the stage for his development and implementation of an effective live vaccine based on a less virulent strain, A. marginale ss. centrale. His 1910 report, describing A. marginale, is among the classic monographs in infectious disease research, presenting not only observations in exacting detail but also highlighting the deductive reasoning leading to association of a new pathogen with a specific disease. With a centennial perspective and both conceptual frameworks and molecular tools unimaginable in Theiler’s time, the significance of several observations in the original report— cyclic bacteremia, strain superinfection, and taxonomic position—is now clear and highlight the broad applicability of key principles of pathogen biology. 76 Sir Arnold Theiler and the discovery of anaplasmosis redwater of cattle in South Africa, was based on his view that animals recovered from infection with B. bigemina should be immune to further challenge with this pathogen. Therefore, when animals delib- erately inoculated with B. bigemina in England and subsequently imported into South Africa underwent a clinically similar disease in the Transvaal, he ad- dressed two alternative hypotheses: (i) the disease was due to a different strain of B. bigemina against which the first strain was not protective; and (ii) the disease was a result of infection with a distinct path- ogen. While identification of antibody and T-lympho- cytes as primary mediators of protective immunity were still decades in the future, his clear understand- ing of the specificity of adaptive immunity was evi- dent and key in his discovery of A. marginale as the etiologic agent of the disease. Much of this first report on A. marginale describes his methodical approach to differentiation of A. marginale from B. bi gemina as separable etiologic agents, each re- sponsible for a specific disease, previously lumped together as redwater or Texas fever. Most impres- sively Theiler used a combination of approaches in- cluding epidemiologic analysis to identify regions where only one of the two diseases were present or where both occurred but at different times of the year, detailed association of microscopic observa- tions with the clinical course of dual and single path- ogen infections, and linkage of specific clinical signs and post-mortem lesions to the diseases caused by each pathogen. Although Theiler’s detailed obser- vations, so characteristic of that era’s leading micro- biologists, illuminate the first report, his critical re- view of the existing literature and observations of other scientists, including Smith & Kilborne in the United States, Knuth & Lignieres in Argentina, and Kossel and his co-workers in Europe, provides evi- dence of his ability to integrate disparate observa- tions into a unifying conclusion. A final characteristic that stands out from Theiler’s initial work on anaplas mosis is the accord paid to the field observations of the farmers themselves that there were often two bouts of disease in cattle occurring at dif ferent times of the year—observa- tions that strengthened Theiler’s initial belief that two distinct pathogens were respons ible and allowed him to correlate microscopic observations with each clinical syndrome. This respect for the insight of farmers is very reminiscent of that which led Smith & Kilborne (1893) to the then unthought-of discov- ery that arthropods could transmit microbial patho- gens. From a centennial perspective, with 100 years of investigation generating a conceptual framework of pathogenic microbiology and immunology unavail- able to Theiler as well as the then unimaginable tools of electron, fluorescence and confocal micro- scopy, PCR and whole genome sequencing, and high-throughput proteomics, it is remarkable how well Theiler’s conclusions have stood the test of time. Furthermore, buried in the 1910 manuscript are several observations which can now be under- stood—a true complement to Theiler in that his ob- servations were so clearly presented. The first of these is his observation that there were cyclic peaks of A. marginale bacteremia. Theiler noted: “Marginal points on 32nd day…62nd day with re-appearance of marginal points.” Unlike African trypanosomes, for which Ross & Thomson (1910) reported cyclic waves of parasitemia, light microscopy has insufficient sen- sitivity to reliably track the fluctuations in A. margin- ale bacteremia, except in the acute and very early post-acute periods observed by Theiler. Although Theiler clearly understood that A. margin- ale persisted in infected animals and that the patho- gen levels were much lower during this phase, the basis for this persistence would remain poorly under- stood until more sensitive detection methods were developed. Initially, Southern hybridization (Kieser, Eriks & Palmer 1990) and then PCR (French, McEl- wain, McGuire & Palmer 1998) allowed definitive detection of the cyclic waves of bacteremia between 102–107 organisms per mℓ of blood during persist- ent infection. These observations, in turn, led to the hypothesis that persistence was mediated by outer membrane protein antigenic variation and subse- quent discovery of the immunodominant and anti- genically-variable Major Surface Protein (Msp)-2 (reviewed in Palmer, Brown & Rurangirwa 2000). Research over the past decade has elucidated how the small (1.2 Mb) A. marginale genome generates the tremendous number of variants needed to evade immune clearance for long-term persistence. This mechanism, termed segmental gene conversion (Palmer & Brayton 2007), uses a combination of re- combination of complete donor alleles and oligonu- cleotide segments of these alleles into a single ex- pression site to generate 103–104 unique Msp-2 variants. Most interesting is that there is compelling evidence that variants generated by recombination of complete donor alleles have a strong in vivo fit- ness advantage (Palmer, Futse, Leverich, Knowles, Rurangirwa & Brayton 2007). These variants arise preferentially in acute infection (during which bac- teremia reaches ≥ 108 A. marginale per mℓ) and in the initial bacteremic peak in the post-acute period (Futse, Brayton, Knowles & Palmer 2005). This in vivo fitness results in bacteremia levels during the 77 G.H. PALMER first post-acute peak that exceed 107 A. marginale per mℓ and thus can be observed microscopically. In contrast, subsequent bacteremic cycles during per- sistent infection are increasingly composed of or- ganisms with less fit variants generated from multi- ple donor alleles and peak at levels just below reliable microscopic detection (Futse et al. 2005; Palmer et al. 2007). This understanding is consist- ent with both the timing and levels observed by Theiler (1910)—detection of the acute and first post- acute bacteremia followed by long-term persistence with retention of infectivity but below levels of micro- scopic detection. This understanding of the interplay between antigenic variation and pathogen fitness is relevant not only to A. marginale but numerous per- sistent microbial pathogens, including the Human Immunodeficiency Virus (HIV) (Goulder & Watkins 2004; Kent, Fernandez, Dale & Davenport 2005). A second observation made by Theiler that can now be explained is the occurrence of strain superinfec- tion. At several places in his original 1910 mono- graph, he notes that re-infection with a milder course of disease occurs and raises the question as to whether this may be attributable to A. marginale strain differences: “An animal may be successfully inoculated more than once, although the second in- oculation will only cause a slight reaction. This sec- ond reaction might be due to a difference in the strain of the anaplasma, the primary reaction gives sufficient ground immunity to protect an animal against severe lesions and death from a subsequent infection.” This observation formed the basis for his subsequent development of a less virulent strain, A. marginale ss. centrale, as a vaccine to prevent se- vere morbidity and death upon challenge with highly virulent A. marginale (Theiler 1911; 1912). However, the basis for this strain superinfection remained un- explored until genome sequencing of multiple A. marginale strains (Brayton, Kappmeyer, Herndon, Dark, Tibbals, Palmer, McGuire & Knowles 2005; Rodriguez, Palmer, Knowles & Brayton 2005) be- gan to provide clues as to how a second strain could evade the immunity induced against an already es- tablished primary strain infection. During infection with the primary strain, immunity is sequentially de- veloped against the MSP2 variants expressed by recombination of complete donor alleles and subse- quently by segmental recombination. Consequently, a second strain must evade this immunity and does so only by encoding at least one distinct variant al- lele in its genome (Futse, Brayton, Dark, Knowles & Palmer 2008). Among highly similar strains with shared variant alleles strain superinfection either does not occur or is rare—the latter perhaps occur- ring in a narrow window following infection with the initial strain, but before broad immunity to the initial variant repertoire has been induced. This same mechanism appears to underlie the use of the A. marginale ss. centrale vaccine as the repertoire of this vaccine strain (Shkap, Molad, Brayton, Brown & Palmer 2002) is distinctly different from the senso stricto A. marginale strains examined to date. Un- derstanding the basis for the strain superinfection first observed by Theiler has a broader impact for infectious diseases. The pressures for genomic di- vergence among microbial pathogens where host immunity against a dominant strain limits new trans- mission, are not unique to A. marginale—similar pressures appear to manifest in pathogens as tax- onomically distinct as HIV, Hepatitis C virus and Trypanosoma brucei (Blackard & Sherman 2007; Hutchinson, Picozzi, Jones, Mott, Sharma, Welburn & Carrington 2007; Piantadosi, Chohan, Chohan, McClelland & Overbaugh 2007). The strain structure of A. marginale is remarkably diverse and serves as an illustrative model as to how pathogens emerge under conditions of natural transmission and specifi- cally how diversification occurs in, unlike the RNA viruses, a relatively genomically stable organism. A final observation now viewed through the prism of time is Theiler’s discussion of the taxonomy of A. marginale. Theiler’s clear statement that this was a specific disease agent, apart from B. bigemina, was highly significant as it led to development of specific vaccines and, later, specific treatments for these dis- eases—similar in several clinical features but with very different etiologies and epidemiology. Theiler’s choice of the genus name Anaplasma reflected his observations that the inclusion lacked any observ- able cytoplasm, distinct from the other intra-erythro- cytic protozoa in which the basophilic nucleus and eosinophilic cytoplasm could be distinguished micro- scopically: “They differ from any known blood para- site by the absence of a protoplasmic body and con- sist only of chromatin substance, thus resembling to a certain extent, the bacteria. They represent, in my opinion, a new genus of protozoa which I propose to call Anaplasma and the species under considera- tion Anaplasma marginale.” Although A. marginale would be variously classified as a virus or protozoa, the initial observations by Theiler are consistent with its correct classification as a novel bacterial genus. Anaplasma marginale was the first rickettsial path- ogen to be identified, although it was not correctly placed in the Order Rickettsiales until the 7th edition of Bergey’s manual in 1957. The genus name has remained and, based on precedent and the guiding principles of bacterial nomenclature, now also gives 78 Sir Arnold Theiler and the discovery of anaplasmosis its name to one of the two families that compose the Order Rickettsiales, Anaplasmataceae (the other be ing the Rickettsiaceae). Interestingly, Cowdry (1925) working in South Africa would identify the first pathogen representative of a second genus, Ehrlichia, in the Family Anaplasmataceae with his discovery of E. ruminantium as the cause of African heartwater. [Cowdry placed the newly discovered organism in the genus Rickettsia. This was later placed in a novel genus, Cowdria, honouring his dis- covery. Recent taxonomic re-organization (Dumler et al. 2001) has unified highly related organisms in the genus Ehrlichia.] The genera Anaplasma and Ehrlichia include the tick-transmitted pathogens with in the Family Anaplasmataceae and it is notable that pioneering work in South Africa established the fundamentals of transmission, pathogenesis and immunity that have now been applied to a greatly ex panded number of animal and human pathogens in these genera. Dumler’s highly cited paper (2001), revising the taxonomy of the Family Anaplasma - taceae, has stood the test of complete genome se- quencing, confirming the relationships among the members, and has led to better understanding of the biology of these organisms and their consequent dis- eases. Thus today, research initiated by Theiler has a widespread impact on understanding pathogen biology far beyond that envisioned a century ago. Anaplasma marginale still holds many challenges for investigation and for improvement of disease control. Among these, three stand out: (i) develop- ment of safe, standardized and effective vaccines; (ii) understanding the basis for age and breed innate resistance; and (iii) understanding transmission dy- namics and virulence leading to severe outbreaks. Despite Theiler’s development of the A. marginale ss. centrale as a live vaccine in 1910/11, disease control remains suboptimal and, along with other tick-borne infections, exacts a disproportionate bur- den on small-holder farmers in resource poor coun- tries (Minjauw & McLeod 2003). Addressing these challenges is incumbent on the research community to both continue the Theiler tradition of disease in- vestigation leading to improvement of animal health and to meet our global responsibilities to enhance human development and well-being. REFERENCES BLACKARD, J.T. & SHERMAN, K.E. 2007. Hepatitis C virus co- infection and superinfection. Journal of Infectious Diseases, 195:519–524. BRAYTON, K.A., KAPPMEYER, L.S., HERNDON, D.R., DARK, M.J., TIBBALS, D.L., PALMER, G.H., MCGUIRE, T.C. & KNOWLES, D.P. 2005. Complete genome sequencing of Ana plasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proceedings of the National Academy of Sciences USA, 102:844–849 COWDRY, E.V. 1925. Etiology of heartwater: Observation of a rickettsia, Rickettsia ruminantium, in tissues of infected ani- mals. Journal of Experimental Medicine, 42:231–252. DUMLER, J.S., BARBET, A.F., BEKKER, C.P., DASCH, G.A., PALMER, G.H., RAY, S.C., RIKIHISA, Y. & RURANGIRWA, F.R. 2001. Reorganization of genera in the families Rickett- si aceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, de- scriptions of six new species combinations and designation of Ehrlichia equi and ‘HE agent’ as subjective synonyms of Ehrlichia phagocytophila. International Journal of Systematic and Evolutionary Microbiology, 51:2145–2165. FRENCH, D.M., McELWAIN, T.F., MCGUIRE, T.C. & PALMER, G.H. 1998. Expression of Anaplasma marginale major sur- face protein 2 variants during persistent cyclic rickettsemia. Infection and Immunity, 66:1200–1207. FUTSE, J.E., BRAYTON, K.A., KNOWLES, D.P. & PALMER, G.H. 2005. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants. Molecular Microbiology, 57:212–221. FUTSE, J.E., BRAYTON, K.A., DARK, M.J., KNOWLES, D.P. & PALMER, G.H. 2008. Superinfection as a driver of genomic diversification in antigenically variant pathogens. Proceedings of the National Academy of Sciences USA, 105:2123–2127. GOULDER, P.J.R. & WATKINS, D.I. 2004. HIV and SIV CTL es- cape: Implications for vaccine design. Nature Reviews Immu- n ology, 4:630–640. HUTCHINSON, O.C., PICOZZI, K., JONES, N.G., MOTT, H., SHARMA, R., WELBURN, S.C. & CARRINGTON, M. 2007. Variant Surface Glycoprotein gene repertoires in Trypano- soma brucei have diverged to become strain-specific. BMC Genomics, 8:234–244. KENT, S.J., FERNANDEZ, C.S., DALE, C.J. & DAVENPORT, M.P. 2005. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Trends in Microbiology, 13:243–246. KIESER, S.T., ERIKS, I.S. & PALMER, G.H. 1990. Cyclic rickett- semia during persistent Anaplasma marginale infection of cat- tle. Infection and Immunity, 58:1117–1119. MINJAUW, B. & MCLEOD, A. 2003. Tick-borne diseases and pov- erty: the impact of ticks and tick-borne diseases on the liveli- hoods of small-scale and marginal livestock owners in India and eastern and southern Africa. DFID Animal Health Pro- gramme, Centre for Tropical Veterinary Medicine, University of Edinburgh. PALMER, G.H., BROWN, W.C. & RURANGIRWA, F.R. 2000. Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale. Microbes and Infection, 2: 167–176. PALMER, G.H. & BRAYTON, K.A. 2007. Gene conversion is a convergent strategy for pathogen antigenic variation. Trends in Parasitology, 23:408–413. PALMER, G.H., FUTSE, J.E., LEVERICH, C.K., KNOWLES, D.P., RURANGIRWA, F.R. & BRAYTON, K.A. 2007. Selec- tion for simple MSP2 variants during Anaplasma marginale transmission to immunologically naïve animals. Infection and Immunity, 75:1502–1506. PIANTADOSI, A., CHOHAN, B., CHOHAN, V., McCLELLAND, R.S. & OVERBAUGH, J. 2007. Chronic HIV-1 infection fre- quently fails to protect against superinfection. PLoS Path- ogens, 3:1745–1760. 79 G.H. PALMER RODRIGUEZ, J.L., PALMER, G.H., KNOWLES, D.P. & BRAY- TON, K.A. 2005. Distinctly different msp2 pseudogene reper- toires in Anaplasma marginale strains that are capable of superinfection. Gene, 361:127–132. ROSS, R. & THOMSON, D. 1910. A case of sleeping sickness studied by precise enumerative methods: regular periodic increase of the parasites disclosed. Annals of Tropical Med- icine and Parasitology, 4:261–264. SHKAP, V., MOLAD, T., BRAYTON, K.A., BROWN, W.C. & PALMER, G.H. 2002. Expression of Major Surface Protein-2 variants with conserved T cell epitopes in Anaplasma cent- rale vaccinates. Infection and Immunity, 70:642–648. SMITH, T. & KILBORNE, F.L. 1893. Investigations into the na- ture, causation, and prevention of Texas or southern cattle fever. US Department of Agriculture Bulletin of the Bureau of Animal Industry, 1:1–301. THEILER, A. 1910. Anaplasma marginale (gen. spec. nov.). The marginal points in the blood of cattle suffering from a specific disease. Report of the government veterinary bacteriologist, 1908–1909. Transvaal, South Africa. THEILER, A. 1911. Further investigations into anaplasmosis of South African cattle. First Report of the Director of Veterinary Research, Union of South Africa. Johannesburg, South Afri- ca. THEILER, A. 1912. Gallsickness of imported cattle and the pro- tective inoculation against this disease. Agricultural Journal of the Union of South Africa, 3:7–46. << /ASCII85EncodePages false /AllowTransparency false /AutoPositionEPSFiles true /AutoRotatePages /None /Binding /Left /CalGrayProfile (Dot Gain 20%) /CalRGBProfile (sRGB IEC61966-2.1) /CalCMYKProfile (Coated FOGRA27 \050ISO 12647-2:2004\051) /sRGBProfile (sRGB IEC61966-2.1) /CannotEmbedFontPolicy /Error /CompatibilityLevel 1.4 /CompressObjects /Tags /CompressPages true /ConvertImagesToIndexed true /PassThroughJPEGImages true /CreateJobTicket false /DefaultRenderingIntent /Default /DetectBlends true /DetectCurves 0.0000 /ColorConversionStrategy /CMYK /DoThumbnails false /EmbedAllFonts true /EmbedOpenType false /ParseICCProfilesInComments true /EmbedJobOptions true /DSCReportingLevel 0 /EmitDSCWarnings false /EndPage -1 /ImageMemory 1048576 /LockDistillerParams false /MaxSubsetPct 100 /Optimize true /OPM 1 /ParseDSCComments true /ParseDSCCommentsForDocInfo true /PreserveCopyPage true /PreserveDICMYKValues true /PreserveEPSInfo true /PreserveFlatness true /PreserveHalftoneInfo false /PreserveOPIComments true /PreserveOverprintSettings true /StartPage 1 /SubsetFonts false /TransferFunctionInfo /Apply /UCRandBGInfo /Preserve /UsePrologue false /ColorSettingsFile () /AlwaysEmbed [ true ] /NeverEmbed [ true ] /AntiAliasColorImages false /CropColorImages true /ColorImageMinResolution 300 /ColorImageMinResolutionPolicy /OK /DownsampleColorImages false /ColorImageDownsampleType /Bicubic /ColorImageResolution 2400 /ColorImageDepth -1 /ColorImageMinDownsampleDepth 1 /ColorImageDownsampleThreshold 1.50000 /EncodeColorImages true /ColorImageFilter /DCTEncode /AutoFilterColorImages true /ColorImageAutoFilterStrategy /JPEG /ColorACSImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /ColorImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000ColorACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /JPEG2000ColorImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 300 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages false /GrayImageDownsampleType /Bicubic /GrayImageResolution 2400 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /GrayImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000GrayACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /JPEG2000GrayImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 1200 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages false /MonoImageDownsampleType /Bicubic /MonoImageResolution 2400 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict << /K -1 >> /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (None) /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False /CreateJDFFile false /Description << /ARA /BGR /CHS /CHT /CZE /DAN /DEU /ESP /ETI /FRA /GRE /HEB /HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke. Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 5.0 i kasnijim verzijama.) /HUN /ITA /JPN /KOR /LTH /LVI /NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit. De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 5.0 en hoger.) /NOR /POL /PTB /RUM /RUS /SKY /SLV /SUO /SVE /TUR /UKR /ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing. Created PDF documents can be opened with Acrobat and Adobe Reader 5.0 and later.) >> /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ << /AsReaderSpreads false /CropImagesToFrames true /ErrorControl /WarnAndContinue /FlattenerIgnoreSpreadOverrides false /IncludeGuidesGrids false /IncludeNonPrinting false /IncludeSlug false /Namespace [ (Adobe) (InDesign) (4.0) ] /OmitPlacedBitmaps false /OmitPlacedEPS false /OmitPlacedPDF false /SimulateOverprint /Legacy >> << /AddBleedMarks false /AddColorBars false /AddCropMarks false /AddPageInfo false /AddRegMarks false /ConvertColors /ConvertToCMYK /DestinationProfileName () /DestinationProfileSelector /DocumentCMYK /Downsample16BitImages true /FlattenerPreset << /PresetSelector /MediumResolution >> /FormElements false /GenerateStructure false /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles false /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /DocumentCMYK /PreserveEditing true /UntaggedCMYKHandling /LeaveUntagged /UntaggedRGBHandling /UseDocumentProfile /UseDocumentBleed false >> ] >> setdistillerparams << /HWResolution [2400 2400] /PageSize [850.394 1133.858] >> setpagedevice